We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Sentinel Lymph Node Biopsy in Early Stages of Oral Squamous Cell Carcinoma Using the Receptor-Targeted Radiotracer 99m Tc-Tilmanocept.
- Authors
Doll, Christian; Steffen, Claudius; Amthauer, Holger; Thieme, Nadine; Elgeti, Thomas; Huang, Kai; Kreutzer, Kilian; Koerdt, Steffen; Heiland, Max; Beck-Broichsitter, Benedicta
- Abstract
Neck management in patients with early-stage, clinically node-negative oral squamous cell carcinoma (OSCC) remains a matter of discussion. Sentinel lymph node biopsy (SLNB) represents a treatment alternative to avoid elective neck dissection (END) in this cohort and different protocols and tracers exist. Here we present the clinical outcome of SLNB using 99mTc-tilmanocept in a two-day protocol in patients suffering from early-stage OSCC. A total of 13 patients (males: 6; females: 7; mean age: 65.7 years, ranging from 47 to 89 years) were included in this study. Most of the patients suffered from an OSCC of the floor of mouth (n = 6), followed by tongue (n = 5) and upper alveolar crest/hard palate (n = 2). Sentinel lymph nodes (SLNs) were successfully identified in all cases (range: 1–7). The average length of hospital stay was 4.7 days (range: 3–8 days) and mean duration of surgical intervention was 121 min (range: 74–233 min). One patient who suffered from an OSCC of the tongue was sentinel lymph node positive (SLN+). The mean follow-up for all sentinel lymph node negative (SLN-) patients (n = 12) was 20.3 months (range: 10–28 months). No local or nodal recurrences were observed within the observation period. In our patient cohort, SLNB using 99mTc-tilmanocept in a two-day protocol proved to be a reliable and safe staging method for patients suffering from early-stage, clinically node-negative OSCC. These results and their possible superiority to colloid tracers have to be confirmed in a prospective randomized controlled study.
- Subjects
SENTINEL lymph node biopsy; SQUAMOUS cell carcinoma; RADIOACTIVE tracers; SENTINEL lymph nodes; TONGUE cancer; HARD palate
- Publication
Diagnostics (2075-4418), 2021, Vol 11, Issue 7, p1231
- ISSN
2075-4418
- Publication type
Article
- DOI
10.3390/diagnostics11071231